07:00 , Oct 26, 2009 |  BC Week In Review  |  Clinical News

ARCHITECT Anti-CCP assay regulatory update

FDA granted 510(k) clearance for Axis-Shield's antibody cyclic-citrulinated peptide (anti-CCP) assay to aid in the diagnosis of rheumatoid arthritis for use on the Architect i1000SR and i2000SR immunoassay systems from Abbott Laboratories (NYSE:ABT, Abbott...